Rosmalen, Netherlands
Rosmalen, Netherlands

Heijmans N.V. is a major European construction-services business with Dutch-based headquarters. Wikipedia.


Time filter

Source Type

News Article | April 25, 2017
Site: globenewswire.com

Over Heijmans Heijmans is een beursgenoteerde onderneming die activiteiten in vastgoed, woningbouw, utiliteit en infra combineert in de werkgebieden Wonen, Werken en Verbinden. Door te sturen op voortdurende kwaliteitsverbetering, innovatie en integraliteit realiseren we toegevoegde waarde voor onze klanten. Heijmans realiseert projecten voor woonconsumenten, bedrijven en overheden en bouwt samen met hen aan de ruimtelijke contouren van morgen. Voor meer informatie, kijk op www.heijmans.nl.


News Article | April 21, 2017
Site: globenewswire.com

Over Heijmans Heijmans is een beursgenoteerde onderneming die activiteiten in vastgoed, woningbouw, utiliteit en infra combineert in de werkgebieden Wonen, Werken en Verbinden. Door te sturen op voortdurende kwaliteitsverbetering, innovatie en integraliteit realiseren we toegevoegde waarde voor onze klanten. Heijmans realiseert projecten voor woonconsumenten, bedrijven en overheden en bouwt samen met hen aan de ruimtelijke contouren van morgen. Voor meer informatie, kijk op www.heijmans.nl.


News Article | May 8, 2017
Site: globenewswire.com

Commissioned by Amsterdam's municipality, Heijmans will develop and build around 150 homes and 650 m2 of commercial space at the N Parcel in Sloterdijk Central. The project is part of the Sloterdijk Central transformation, where the municipality wants to transform the area around the Amsterdam Sloterdijk station into a mixed residential and working area. The project is valued at around € 52 million. The design breaks away from the monotonous image of the existing office buildings. Heijmans thus fulfils Amsterdam municipality's objective well, to transform the area and connect it with existing residential areas and facilities. Heijmans will develop both a low-rise and a high-rise building (around 20,000 m2), and will create various roof gardens and a parking garage. The low-rise will comprise around 10 deep and high loft-homes and 40 so-called garden-lofts. The high-rise will have around 100 loft-apartments with a living space ranging from 50 to 200 m2. The loft-apartments can be divided to meet the buyers' wishes. The commercial spaces (plinth) in the low-rise will become a connecting meeting area for residents, visitors and entrepreneurs. Heijmans is the first developer to create 150 new-build homes in the area, and is expected to start building the project at the end of 2018. Heijmans had already been given the commission to carry out the Spaarndammerhart project in Amsterdam (74 homes) in November 2016. Sustainability and the quality of the design and submission were also deciding factors in awarding this project. In developing projects like the N Parcel Sloterdijk Central and Spaarndammerhart, Heijmans makes the environment, the perception, the quality and the residents paramount. With its projects, Heijmans contributes to activating residential areas. The design has been drawn up in collaboration with: NL architects, Donna van Milligen Bielke, Chris Collaris, Space Encounters and DS landschapsarchitecten. About Heijmans Heijmans is a listed company that combines activities related to property development, residential building, non-residential building, roads and civil engineering in the fields living, working and connecting. Our constant focus on quality improvements, innovation and integrated solutions enables us to generate added value for our clients. Heijmans realises projects for private consumers, companies and public sector bodies and, in partnership with its clients, is building the spatial contours of tomorrow. You will find additional information on www.heijmans.nl For additional information / not for publication: Media Rik Hammer  Communications +31 73 543 52 17 rhammer@heijmans.nl Analysts Guido Peters Investor Relations +31 73 543 52 17 gpeters@heijmans.nl A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/803db3cf-f772-4e51-a781-e8b5333ba4ab


News Article | May 1, 2017
Site: www.prnewswire.com

Mr. Coury continued, "As Mylan continues its evolution as a leading global healthcare company, we will continue to seek out additional candidates who can further strengthen our Board by bringing fresh perspectives that can add to our Board's already broad diversity and experience. Nominating Sjoerd accomplishes just that. He brings to Mylan a phenomenal breadth of leadership experience across a variety of industries and a new, independent perspective on how to maximize the many potential opportunities we see ahead for our company. He also brings a strong history of prior senior level executive management experience and currently serves on the boards of directors of other Dutch companies." Vollebregt currently serves as the chairman of the Supervisory Board of Heijmans N.V., a Euronext Amsterdam listed company operating in property development, residential building, non-residential building, roads and civil engineering, and as chairman of the Advisory Board of Airbus Defence and Space Netherlands B.V., a subsidiary of Airbus SE, a Euronext Paris listed company, that develops solar arrays, satellite instruments and structures for launchers. Previously, Vollebregt served as chairman of the Executive Board of Stork B.V., an Amsterdam Stock Exchange-listed industrial group, and as chief executive officer of Fokker Technologies Group B.V., an aerospace company and a Stork B.V. subsidiary. Vollebregt also has previously served as a member of the Supervisory Board of TNT Express N.V., an international courier delivery services company, and has held various other senior positions at Exel plc, Ocean plc, Intexo Holding and Royal Van Ommeren. Vollebregt said, "I am honored to have been nominated for election to the Mylan N.V Board.  I have had the privilege and opportunity to spend a great deal of time in getting to know Mylan, its Board of Directors and management team, and, if elected, I am very confident that I will be able to contribute to this strong, dynamic group of leaders. Mylan has an extraordinarily rich history of growth and success, and has truly differentiated itself in the global pharmaceutical industry in its quest to benefit shareholders and all other stakeholders." This press release includes statements that constitute "forward-looking statements." These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include statements about how Mylan continues to evolve into a leading global healthcare company and about maximizing the many opportunities Mylan sees ahead for itself. Because forward-looking statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such statements. Factors that could cause or contribute to such differences include, but are not limited to any changes in, interruptions to, or difficulties with Mylan's or its partners' ability to develop, manufacture, and commercialize products; the effect of any changes in Mylan's or its partners' customer and supplier relationships and customer purchasing patterns; other changes in third-party relationships; the impact of competition; changes in the economic and financial conditions of the businesses of Mylan or its partners; the scope, timing, and outcome of any ongoing legal proceedings and the impact of any such proceedings on Mylan's or its partners' business; any regulatory, legal, or other impediments to Mylan's or its partners' ability to bring products to market; actions and decisions of healthcare and pharmaceutical regulators, and changes in healthcare and pharmaceutical laws and regulations, in the United States and abroad; Mylan's and its partners' ability to protect intellectual property and preserve intellectual property rights; risks associated with international operations; other uncertainties and matters beyond the control of management; and the other risks detailed in Mylan's filings with the Securities and Exchange Commission. Mylan undertakes no obligation to update these statements for revisions or changes after the date of this release. Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We market a growing portfolio of approximately 7,500 products around the world, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mylan-nominates-sjoerd-vollebregt-for-election-to-board-of-directors-300448605.html


Grant
Agency: European Commission | Branch: H2020 | Program: IA | Phase: IoT-01-2016 | Award Amount: 20.05M | Year: 2017

SynchroniCity represents the first attempt to deliver a Single Digital City Market for Europe by piloting its foundations at scale in 11 reference zones - 8 European cities & 3 more worldwide cities - connecting 34 partners from 11 countries over 4 continents. Building upon a mature European knowledge base derived from initiatives such as OASC, FIWARE, FIRE, EIP-SCC, and including partners with leading roles in standardization bodies, e.g. ITU, ETSI, IEEE, OMA, IETF, SynchroniCity will deliver a harmonized ecosystem for IoT-enabled smart city solutions where IoT device manufacturers, system integrators and solution providers can innovate and openly compete. With an already emerging foundation, SynchroniCity will establish a reference architecture for the envisioned IoT-enabled city market place with identified interoperability points and interfaces and data models for different verticals. This will include tools for co-creation & integration of legacy platforms & IoT devices for urban services and enablers for data discovery, access and licensing lowering the barriers for participation on the market. SynchroniCity will pilot these foundations in the reference zones together with a set of citizen-centred services in three high-impact areas, showing the value to cities, businesses and citizens involved, linked directly to the global market. With a running start, SynchroniCity will serve as lighthouse initiative to inspire others to join the established ecosystem and contribute to the emerging market place. SynchroniCity takes an inclusive approach to grow the ecosystem by inviting businesses and cities to join through an open call, allowing them to participate on the pioneering market place enabling a second wave of successful pilots. They will strengthen the ecosystem by creating a positive ripple effect throughout Europe, and globally, to establish a momentum and critical mass for a strong European presence in a global digital single market of IoT-enabled solutions.


Grant
Agency: European Commission | Branch: FP7 | Program: JTI-CP-FCH | Phase: SP1-JTI-FCH.2010.2.4 | Award Amount: 3.06M | Year: 2012

The aim of HyTime is to deliver a bioprocess for decentral H2 production from 2nd generation biomass with a productivity of 1-10 kg H2/d. The novel strategy in HyTime is to employ thermophilic bacteria which have shown superior yields in H2 production from biomass in the previous FP6 IP HYVOLUTION. Biomass in HyTime is grass, straw, molasses or unsold organic goods from supermarkets. The biomass is fractionated and converted to H2 at high efficiency unique for thermophilic fermentation. Dedicated bioreactors and gas upgrading devices for biosystems will be constructed to increase productivity. The H2 production unit will be independent of external energy supply by applying anaerobic digestion to valorize residues. HyTime adds to the security of supply H2 from local sources and eradicates geopolitical dependence. HyTime builds on HYVOLUTION with 5 partners expanding their research efforts. Three new industrial partners, 2 of which are NEW-IG members, have joined this team with specialist expertise in 2nd generation biomass fractionation and gastechnology. This way a pan-european critical mass in agro- and biotechnological research, the energy and hydrogen sector is assembled to enforce a breakthrough in bioH2 production. The participation of prominent specialists with interdisciplinary competences from academia (1 research institute and 2 universities) and industries (3 SMEs and 2 industries) warrants high scientific quality and rapid commercialization by exploitation of project results and reinforces the European Research Area in sustainable issues. The partners in HyTime have a complementary value in being developers or stake-holders for new market outlets or starting specialist enterprises stimulating new agro-industrial activities to boost the realization of H2 from renewable resources. The concept of HyTime will facilitate the transition to a hydrogen economy by increasing public awareness of the benefits of a clean and renewable energy carrier.


Patent
Heijmans, Socea NV and Frank GmbH | Date: 2014-07-16

The invention relates to pipes for transporting a liquid, wherein a pipe comprises an inner shell and an outer shell which is coaxial with respect to the inner shell, wherein the inner shell of the pipe is provided with a heat exchanger for transferring heat from the first liquid in the pipe to a second liquid in the heat exchanger, wherein the heat exchanger is provided with a first connection and a second connection for transporting the second liquid. The invention also relates to a pipeline section composed of such pipes and to a pipeline composed of such pipeline sections.


Patent
Heijmans | Date: 2014-04-23

The present invention relates to a road marking comprising a profile comprising a luminescent component, which is to be installed in the road surface, in which profile one or more light sources are present and the aforesaid luminescent component is located above said one or more light sources. The profile is made of an elastic material, wherein the part of the profile present at the surface of the road surface is translucent.


The present invention relates to a method for the treatment with a liquid agent of an asphalt structure, in particular an asphalt structure which comprises a porous asphalt surface course, using an air flow directed at the aforesaid asphalt structure, wherein said treatment comprises the following steps:i) spraying a liquid binder onto the surface course of the aforesaid asphalt structure;ii) directing a concentrated air flow at the liquid binder sprayed onto the aforesaid surface course in step i), wherein step ii) is carried out in such a manner that the spraying according to step i) and the directing of the air flow according to step ii) are carried out as separate steps, so that the aforesaid liquid binder will penetrate through the surface course, forming a sealing layer of binder in the aforesaid surface course in a region near the bottom side of the surface course.


The invention relates to a method for manufacturing pellets from municipal waste incinerator bottom ash comprising separating a fraction with a particle size in the range from 0 to 6 mm from the municipal waste incinerator bottom ash, mixing the fraction with a binder, adjustment of moisture content by adding water to form a wet mix and pelletizing the wet mix. The invention also relates to concrete products comprising pellets formed by such method.

Loading Heijmans collaborators
Loading Heijmans collaborators